Duration of condition is unrelated to health-state valuation on the EuroQol

Clinical Rehabilitation

Volumn 17, Issue 2, 2003, Pages 209-215

  Myers, Julia A ^a   McPherson, Kathryn M ^a,b   Taylor, William J ^a   Weatherall, Mark ^a   McNaughton, Harry K ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CONTROLLED STUDY; COVARIANCE; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; EUROPE; EXPERIENCE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; POPULATION RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; STROKE; TIME;

ADAPTATION, PSYCHOLOGICAL; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CEREBROVASCULAR ACCIDENT; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEW ZEALAND; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 0037333768     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215503cr602oa     Document Type: Article

References (22)

1. Devlin NJ, Hansen P, Kind P, Williams AH. The health-state preferences and logical inconsistencies of New Zealanders: A tale of two tariffs. Discussion paper 180, University of York Centre for Health Economics, 2000.
2. Brooks R. EuroQoL: The current state of play. Health Policy 1996; 37: 53-72.
3. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: Results from a UK general population survey. Discussion paper 138. York: University of York, 1995.
4. de Wit A, Busschbach J, de Charro F. Sensitivity and perspective in the valuation of Health Status: Whose Values Count? Health Econ 2000; 9: 109-26.
5. Dolan P. Whose preferences count? Med Decis Making 1999; 19: 482-86.
6. Ubel PA, Richardson J, Menzel P. Societal value, The person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ 2000; 9: 127-36.
7. Polsky D WR, Scott K, Schulman KA, Glick HA. A comparison of scoring weights for the EuroQol derived from patients and the general public. Health Econ 2001; 10: 27-37.
8. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H. Validity of EuroQoL - a generic health status instrument - in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol 1994; 33: 655-62.
9. Fransen M, Edmonds J. Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology 1999; 38: 807-13.
10. Dolan P. The effect of experience of illness on health-state valuations. J Clin Epidemiol 1996; 49: 551-64.
11. Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 1998; 13: 687-96.
12. Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D. A cost-utility analysis of interferon beta for multiple sclerosis. Health Technol Assess (South Hampton, NY) 1998; 2: iii-54.
13. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
14. Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Assess (South Hampton, NY) 1999; 3(9): i-iv, 1-164.
15. Bonita R, Anderson CS, Broad JB, Jamrozik KD, Stewart-Wynne EG, Anderson NE. Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based registers. Stroke 1994; 25: 522-27.
16. Bonita R, Broad JB, Beaglehole R. Ethnic differences in stroke incidence and case fatality in Auckland, New Zealand. Stroke 1997; 28: 758-61.
17. Miller D. The natural history of multiple sclerosis: a regional study with some longitudinal data. J Neurol Neurosurg Psychiatry 1992; 55: 341-46.
18. Gudex C, Dolan P, Kind P, Williams A. Health state valuations from the general public using the visual analogue scale. Qual Life Res 1996; 5: 521-31.
19. Addington-Hall J, Kalra L. Who should measure quality of life? BMJ 2001; 322: 1417-20.
20. Taylor WJ, Lord S, McPherson KM, McNaughton HK. EuroQol EQ-5D may not adequately describe the health status of people with disabilities. Disabil Rehabil 2001; 23: 281-85.
21. Dorman PJ, Waddell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke 1997; 28: 1876-82.
22. Devlin N, Williams A. Valuing quality of life: results for New Zealand health professionals. NZ Med J 1999; 112: 68-71.